Formulation and optimization of carbamazepine floating tablets

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 6, 2007, Pages 763-767

  Patel, D ^a   Patel, N ^b   Pandya, N ^b   Jogani, P ^c  

^a Shri Sarvajanik Pharmacy College   (India)

^b Shri B M Shah College of Pharmacy Modasa   (India)

^c ZYDUS RESEARCH CENTRE   (India)

Author keywords

Carbamazepine; Floating tablet; Melt granulation; Simplex lattice design

Indexed keywords

BICARBONATE; CARBAMAZEPINE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HUMIDITY; HYDRATION; HYDROPHOBICITY;

EID: 40749160130     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0250-474X.39430     Document Type: Article

References (25)

1. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: Gel layer behavior, mechanism and optimal performance. Pharm Sci Technol Today 2000;3:1-8.
2. Baumgartner S, Kristi J, Vrecer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 2000;195:125-35.
3. Santus G, Lazzarini G, Bottoni G. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm 1997;44:39-52.
4. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Develop Ind Pharm 1996;22:531-9.
5. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res 1997;14:815-9.
6. Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci 1994;83:239-45.
7. Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J Control Release 1998;55:3-12.
8. Singh B, Kim K. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235-59.
9. Chawla G, Bansal A. A means to address regional variability in intestinal drug absorption. Pharm Tech 2003;27:50-68.
10. Larkin JG, Mecllelan A, Munday A, Sutherland M, Bulter E, Brodie MJ. A double blind comparison of conventional and controlled release formulations of carbamazepine in healthy subjects. Br J Clin Pharm 1989;27:313-22.
11. Giunchedi P, Conte U, La Manna A. Carbamazepine modified release dosage forms. Drug Develop Ind Pharm 1991;17:1753-64.
12. Giunchedi P, Maggi L, Conte U, La Manna A. Linear extended release of a water insoluble drug, carbamazepine, from erodible matrix. Int J Pharm 1993;94:15-22.
13. Stevens RE, Limsakun T, Evans G, Mason DH. Controlled multidose pharmacokinetic evaluation of two extended release carbamazepine formulations (Carbatrol and Tegretol XR). J Pharm Sci 1998;87:1531-4.
14. Rosa M, Zia H, Rhodes T. Dosing and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 1994;105:65-70.
15. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 283.
16. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-7.
17. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
18. Hixon AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Engg Chem 1931;23:923-31.
19. Korsmeyer R, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
20. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-1.
21. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix: Swelling and dissolution. Pharm Res 1988;5:488-94.
22. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmcol 1988;24:979-81.
23. Goldsmith JA, Randall N, Ross SD. Methods of expressing dissolution rate data. J Pharm Pharmacol 1978;30:347-9.
24. Romero P, Costa JB, Chulia D. Statistical optimization of a controlled release formulation obtained by a double compression process: Application of a Handmade matrix and factorial design. In: Wells JI, Rubistein MH, Horwood E, editors. Pharmaceutical Technology, Contorlled Drug Release. Vol 2. New York, NY: Ellis Harwood; 1991. p. 44-58.
25. Bamba M, Puisieux F. Release mechanisms in gel forming sustained release preparation. Int J Pharm 1979;2:307-15.